Lynparza receives positive EU CHMP opinion for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer Read more
Cardinal Health Specialty Solutions Strengthens Cell and Gene Therapy Offering with PANTHERx Specialty Pharmacy Collaboration Read more
GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above Read more
ZynquistaTM now approved in the European Union for treatment of adults with type 1 diabetes Read more
FDA Approves Praluent (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization Read more
Lonza’s Fully Automated Plate-Based Robotic Solution Enables Simple, Fast and Reliable Endotoxin Detection Read more
Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to NASH Read more
ACADIA Pharma Initiates Phase 3 CLARITY Program with Pimavanserin as Adjunctive Treatment for Major Depressive Disorder Read more